027360.KQ

Aju IB Investment Co., Ltd. [027360.KQ] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

027360.KQ Stock Summary

Earnings have grown 134.65% per last year.

The Moving Average Convergence Divergence (MACD) for 027360.KQ recently turned positive (within last 10 days).

Earnings are expected to fall -100% next year

Profit margins (0.28%) are lower than the previous year (0.3%)

027360.KQ has less than 1 year of cash runway

Top 10 Correlated Stocks

027360.KQ

In the News

027360.KQ Financial details

Company Rating

Buy

Market Cap

314.11B

Income

16.6B

Revenue

55.84B

Book val./share

2184.97

Cash/share

707.72

Dividend

Dividend %

0.66%

Employees

Optionable

Shortable

Yes

Earnings

12 Mar 2021

P/E

25.16

Forward P/E

PEG

0.35

P/S

P/B

1.41

P/C

3.79

P/FCF

7.07

Quick Ratio

4.21

Current Ratio

4.21

Debt / Equity

0.1

LT Debt / Equity

0.08

EPS (TTM)

140.66

EPS next Y

EPS next Q

EPS this Y

712.72%

EPS next Y

EPS next 5Y

EPS last 5Y

0.46%

Revenue last 5Y

9.65%

Revenue Q/Q

6.3%

EPS Q/Q

206.42%

SMA20

2.9%

SMA50

-1.03%

SMA100

23.3%

Inst Own

Inst Trans

ROA

ROE

ROC

0.09%

Gross Margin

100%

Oper. Margin

64%

Profit Margin

28%

Payout

16%

Shs Outstand

Shs Float

Target Price

52W Range

1971.0-3185.0

52W High

-15.86%

52W Low

+35.97%

RSI

56.44

Rel Volume

0.67

Avg Volume

333.35K

Volume

222.68K

Perf Week

-0.37%

Perf Month

1.9%

Perf Quarter

24.65%

Perf Half Y

27.92%

Beta

0.777742

Volatility

25.19%, 53.59%

Prev Close

Price

2680

Change

2.49%

027360.KQ Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-12-31

Metric	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	296.99	299.07	512.35	201.78	472.66
Net income per share	137.34	429.31	339.37	17.29	140.52
Operating cash flow per share	218.66	-26.74	491.64	187.97	210.57
Free cash flow per share	218.32	-28.64	488.91	182.44	209.44
Cash per share	370.3	487.46	708.88	381.84	708.7
Book value per share	1.41K	1.82K	2.18K	2.06K	2.19K
Tangible book value per share	2.23K	2.82K	2.68K	2.58K	2.49K
Share holders equity per share	1.41K	1.82K	2.18K	2.06K	2.19K
Interest debt per share	333.58	439.75	306.55	307.18	231.08
Market cap	147.66B	459.47B	463.61B	261.24B	336.13B
Enterprise value	161.12B	494.34B	473.02B	285.15B	320.95B
P/E ratio	9.07	9.29	11.79	128.12	20.25
Price to sales ratio	4.19	13.34	7.81	10.98	6.02
POCF ratio	5.69	-149.24	8.14	11.78	13.51
PFCF ratio	5.7	-139.29	8.18	12.14	13.58
P/B Ratio	0.88	2.19	1.83	1.07	1.3
PTB ratio	0.88	2.19	1.83	1.07	1.3
EV to sales	4.57	14.35	7.97	11.98	5.75
Enterprise value over EBITDA	7.61	16.45	14.7	313.26	13.68
EV to operating cash flow	6.21	-160.57	8.3	12.86	12.9
EV to free cash flow	6.22	-149.86	8.35	13.25	12.97
Earnings yield	0.11	0.11	0.08	0.01	0.05
Free cash flow yield	0.18	-0.01	0.12	0.08	0.07
Debt to equity	0.23	0.23	0.14	0.14	0.1
Debt to assets	0.12	0.12	0.09	0.09	0.07
Net debt to EBITDA	0.64	1.16	0.29	26.27	-0.65
Current ratio	9.02	1.88	1.46	1.56	0
Interest coverage	14.29	21.63	23.95	-0.58	12.94
Income quality	1.59	-0.06	1.45	10.87	1.5
Dividend Yield	0.02	0.01	0.01	0.05	0.01
Payout ratio	0.18	0.08	0.15	5.78	0.14
Sales general and administrative to revenue	0.01	0.01	0	0.01	0
Research and developement to revenue	0	0	0	0	0
Intangibles to total assets	0	0	0	0	0
Capex to operating cash flow	0	0.07	-0.01	-0.03	-0.01
Capex to revenue	0	-0.01	-0.01	-0.03	0
Capex to depreciation	-0.28	-0.3	-0.23	-0.39	-0.07
Stock based compensation to revenue	0.01	0.01	0	0	0
Graham number	2.09K	4.2K	4.08K	896.05	2.63K
ROIC	0.07	0.06	0.06	-0.01	0.07
Return on tangible assets	0.05	0.12	0.1	0.01	0.05
Graham Net	20.67	-107.19	69.68	-89.82	272.84
Working capital	22B	6.77B	9.04B	5.76B	-1.64B
Tangible asset value	264.39B	324.23B	310.08B	304.76B	294.75B
Net current asset value	-26.72B	-67.31B	-60.3B	-51.54B	-59.86B
Invested capital	0.23	0.23	0.14	0.14	0.1
Average receivables	6.66B	15.53B	18.88B	17.95B	13.52B
Average payables	1.32B	4.76B	12.69B	13.53B	4.28B
Average inventory	0	0	0	0	0
Days sales outstanding	138.08	187.87	123.09	243.46	72.93
Days payables outstanding	113.08	60.79	806.43	245.68	0
Days of inventory on hand	0	0	0	0	0
Receivables turnover	2.64	1.94	2.97	1.5	5
Payables turnover	3.23	6	0.45	1.49	0
Inventory turnover	0	0	0	0	0
ROE	0.1	0.24	0.16	0.01	0.06
Capex per share	-0.33	-1.91	-2.73	-5.53	-1.13

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q4

Metric	2022-12-31	2023-03-31	2023-06-30	2023-09-30	2023-12-31
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	40.01	84.06	138.68	121.13	128.74
Net income per share	1.24	76.72	37.97	6.39	19.58
Operating cash flow per share	71.18	162.4	85.24	81	-117.65
Free cash flow per share	71.17	162.4	85.24	79.98	-117.75
Cash per share	381.84	486.44	679.57	677.93	707.72
Book value per share	2.06K	2.12K	2.17K	2.17K	2.18K
Tangible book value per share	2.58K	2.59K	2.61K	2.54K	2.49K
Share holders equity per share	2.06K	2.12K	2.17K	2.17K	2.18K
Interest debt per share	299.34	299.76	294.19	241.01	220.14
Market cap	261.24B	272.44B	276.22B	240.12B	336.59B
Enterprise value	285.15B	275.43B	263.88B	221.3B	321.41B
P/E ratio	444.81	7.53	15.41	79.44	36.33
Price to sales ratio	55.36	27.48	16.87	16.76	22.1
POCF ratio	31.12	14.22	27.45	25.06	-24.18
PFCF ratio	31.12	14.22	27.45	25.38	-24.16
P/B Ratio	1.07	1.09	1.08	0.94	1.3
PTB ratio	1.07	1.09	1.08	0.94	1.3
EV to sales	60.42	27.78	16.12	15.45	21.1
Enterprise value over EBITDA	205.1	29.82	32.28	57.46	146.39
EV to operating cash flow	33.97	14.38	26.23	23.1	-23.09
EV to free cash flow	33.97	14.38	26.23	23.39	-23.07
Earnings yield	0	0.03	0.02	0	0.01
Free cash flow yield	0.03	0.07	0.04	0.04	-0.04
Debt to equity	0.14	0.14	0.13	0.11	0.1
Debt to assets	0.09	0.09	0.09	0.08	0.07
Net debt to EBITDA	17.2	0.32	-1.51	-4.89	-6.91
Current ratio	1.56	3.84	4.21	0	0
Interest coverage	2.37	23.01	17.57	7.67	4.17
Income quality	57.18	2.12	2.24	12.68	-6.01
Dividend Yield	0	0	0.01	0	0
Payout ratio	0	0	0.53	0	0
Sales general and administrative to revenue	0.01	0.01	0	0	0
Research and developement to revenue	0	0	0	0	0
Intangibles to total assets	0	0	0	0	0
Capex to operating cash flow	0	0	0	-0.01	0
Capex to revenue	0	0	0	-0.01	0
Capex to depreciation	0	0	0	-0.24	-0.02
Stock based compensation to revenue	0	0	0	0	0
Graham number	240.45	1.91K	1.36K	558.28	981.03
ROIC	-0.01	0.03	0.02	0.01	0.01
Return on tangible assets	0	0.02	0.01	0	0.01
Graham Net	-89.82	4.21	167.69	218.58	272.46
Working capital	5.76B	27.06B	38.85B	-1.65B	-1.64B
Tangible asset value	304.76B	305.17B	308.19B	300.53B	294.75B
Net current asset value	-51.54B	-33.35B	-17.13B	-61.65B	-59.86B
Invested capital	0.14	0.14	0.13	0.11	0.1
Average receivables	15.68B	16.63B	13.8B	9.98B	10.45B
Average payables	9.07B	8.2B	9.1B	5.18B	0
Average inventory	0	0	0	0	0
Days sales outstanding	302.73	157.88	56.15	61.24	65.93
Days payables outstanding	339.59	789.23	1.48K	0	0
Days of inventory on hand	0	0	0	0	0
Receivables turnover	0.3	0.57	1.6	1.47	1.37
Payables turnover	0.27	0.11	0.06	0	0
Inventory turnover	0	0	0	0	0
ROE	0	0.04	0.02	0	0.01
Capex per share	-0.01	0	0	-1.02	-0.1

027360.KQ Dividend History

027360.KQ Frequently Asked Questions

What is Aju IB Investment Co., Ltd. stock symbol ?

Aju IB Investment Co., Ltd. is a KR stock and trading under the symbol 027360.KQ

What is Aju IB Investment Co., Ltd. stock quote today ?

Aju IB Investment Co., Ltd. stock price is $2680 today.

Is Aju IB Investment Co., Ltd. stock public?

Yes, Aju IB Investment Co., Ltd. is a publicly traded company.

Something similar

Top by Market Cap

Same Sector

Top Correlated Stocks

Similar Market Cap

Company Profile

Volume Average 333.35K
Market Capitalization 314.11B
Employee 51
CEO Mr. Ji-Won Kim
Headquarters Seoul,KR
IPO Date 2018-11-21
Website http://www.ajuib.co.kr

Aju IB Investment Co., Ltd. is a venture capital and private equity arm of AJU Corporation Co., Ltd. It specializes in mezzanine, buyouts, corporate restructuring, and all stages of venture investments in small to medium sized start-up companies in South Korea. The firm considers investments in information technology including mobile service platforms, software, semiconductor, contents, biotechnology, life science, and environment sectors. For venture capital investments, it focuses on high technology sector and for private equity investments, the firm focuses on manufacturing sector. It typically invests in South Korea but also makes investments in other countries. The firm also considers investments in companies with main business in immune system platform technology, oncology drugs, and ophthalmic drugs. It also invests in information communication technology including Internet of Things, artificial intelligence, smart car, and advanced materials. The firm considers investments in companies that have been evaluated by technology credit bureaus or in companies with ratings of T5 and above, which is provided by technology credit bureaus. For the investments by the office in Boston, Massachusetts, the firm primarily invests in therapeutics serving large unmet medical need; enabling platform technologies with maturing lead candidate; potential for partnership or alliance with Korean pharmaceutical companies; other areas of interest are medical devices & diagnostics. It prefers to invest between $0.87 million to $2.61 million for venture capital investments and $4.36 million to $17.45 million for private equity investments. The firm typically exits through IPO and mergers and acquisitions. Aju IB Investment Co., Ltd., formerly known as Kibo Technology Advancing Capital Co., was founded in 1974 and is based in Seoul, South Korea with an additional office in Boston, Massachusetts.